Phenobarbital for the management of severe acute alcohol withdrawal (the PHENOMANAL trial): a pilot randomized controlled trial

Abstract Background Benzodiazepines are considered first-line treatment for patients experiencing severe acute alcohol withdrawal syndrome (sAAWS). Although several medications have been evaluated as potential adjuvant treatments for sAAWS, barbiturates show particular promise. Objective In the PHEN...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Niall Filewod, Stephen Hwang, Christian J. Turner, Leena Rizvi, Sara Gray, Michelle Klaiman, Danielle Buell, Johnathan Ailon, Alexander Caudarella, Galo F. Ginocchio, Marlene Santos, Gyan Sandhu, Norman Dewhurst, Kelly Sequeira, Karen E. A. Burns
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2022-01-01
سلاسل:	Pilot and Feasibility Studies
الموضوعات:	Phenobarbital; Alcohol withdrawal Delirium tremens Treatment
الوصول للمادة أونلاين:	https://doi.org/10.1186/s40814-021-00963-4
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!